Not Yet RecruitingPhase 2

MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus

200 participantsStarted 2026-03-01

Plain-language summary

To determine the effect of MLD10 (magnesium L-lactate dihydrate extended-release caplets) 10 mEq BID on serum magnesium in Type 2 diabetic patients with hypomagnesemia.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Females and males with Type 2 diabetes mellitus * Body Mass Index between 18 to 40 kg/m2, inclusive, at Screening * Hypomagnesemia defined as serum magnesium ≤ 1.5 mg/dL at Screening * Females must be non-pregnant, non-lactating, and have a negative serum pregnancy test before enrollment. Exclusion Criteria: * History of clinically significant GI, renal, hepatic, neurologic, hematologic, endocrine other than Type 2 diabetes mellitus, oncologic, pulmonary, immunologic, psychiatric, or cardiovascular disease.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Serum Magnesium Concentration

Timeframe: Three months after the initiation of treatment and then at 3 months after the start of the random off phase.

Trial details

NCT IDNCT03567824

SponsorPharmalyte Solutions LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2028-04-30

Contact for this trial

Steve F Brandon

817.421.2777 sbrandon@niche-inc.com

View on ClinicalTrials.gov More Hypomagnesemia in Type 2 Diabetic Patients trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.